Ralfinamide
CAS No. 133865-88-0
Ralfinamide( FCE-26742A | Priralfinamide )
Catalog No. M20711 CAS No. 133865-88-0
Ralfinamide is an orally available Na-channel blocker for the treatment of neuropathic pain and other pain conditions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 31 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 59 | In Stock |
|
| 50MG | 107 | In Stock |
|
| 100MG | 164 | In Stock |
|
| 200MG | 242 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRalfinamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionRalfinamide is an orally available Na-channel blocker for the treatment of neuropathic pain and other pain conditions.
-
DescriptionRalfinamide is an orally available Na-channel blocker for the treatment of neuropathic pain and other pain conditions.(In Vivo):Ralfinamide (30 mg/kg, 60 mg/kg; p.o.; twice daily; 42 days) treated with Ralfinamide (80 mg/kg; p.o.; twice daily; 7 days) preoperatively suppresses neuropathic pain.
-
In Vitro——
-
In VivoRalfinamide (30 mg/kg, 60 mg/kg; p.o.; twice daily; 42 days) treated with Ralfinamide (80 mg/kg; p.o.; twice daily; 7 days) preoperatively suppresses neuropathic pain. Animal Model:81 adult male Sprague–Dawley male rats (260–460 g)Dosage:80 mg/kg (7 days preoperatively), 30 mg/kg, 60 mg/kg (postoperative)Administration:Oral gavage; twice daily; until postoperative day 42Result:Suppressed neuropathic pain.
-
SynonymsFCE-26742A | Priralfinamide
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorNa-channel
-
Research AreaNeurological Disease
-
IndicationNeuropathic pain
Chemical Information
-
CAS Number133865-88-0
-
Formula Weight302.34
-
Molecular FormulaC17H19FN2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (413.44 mM)
-
SMILESC[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O
-
Chemical Name(2S)-2-(4-(2-Fluorobenzyloxy)benzylamino)propanamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Liang X Yu G Su R . Effects of ralfinamide in models of nerve injury and chemotherapy-induced neuropathic pain[J]. European journal of pharmacology 2018 823:27-34.
molnova catalog
related products
-
APETx2
Acid-sensing ion channel 3 (ASIC3) channel blocker (IC50 values are 63 and 175 nM for homomeric rat and human ASIC3 channels). Also inhibits NaV1.8 and NaV1.2 channels (IC50 values are 55 and 114 nM respectively). Demonstrates analgesic properties against acid-induced and inflammatory pain.
-
Oxcarbazepine
Oxcarbazepine is structurally a derivative of carbamazepine, adding an extra oxygen atom to the benzylcarboxamide group.
-
AZD-1305
AZD-1305 is a novel antiarrhythmic agent that predominantly blocks the rapid component of Ikr.
Cart
sales@molnova.com